⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7856029 | 0.78 | — | — | |
| SCHEMBL93292 | 0.75 | — | — | |
| SCHEMBL7856027 | 0.75 | — | — | |
| SCHEMBL5386710 | 0.73 | — | — | |
| SCHEMBL79779 | 0.73 | — | — | |
| SCHEMBL9268689 | 0.73 | — | — | |
| SCHEMBL3118270 | 0.73 | — | — | |
| SCHEMBL8721593 | 0.73 | — | — | |
| SCHEMBL10640209 | 0.73 | — | — | |
| SCHEMBL18139663 | 0.73 | TDP1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024091979-A1 | CD276 (B7-H3) ANTIBODY-DRUG CONJUGATES | BRICKBIO, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2001040306-A9 | HUMAN ANTIBODIES AS DETECTION REAGENTS | BIOSITE DIAGNOSTICS INC (US) | 2002-05-30 | — | — | WO | claimed |
| US-20250241872-A1 | AFFINITY MEDICANT CONJUGATE | Illudent, Inc. (US) | 2025-07-31 | — | — | US | disclosed |
| WO-2024091979-A1 | CD276 (B7-H3) ANTIBODY-DRUG CONJUGATES | BRICKBIO, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| EP-4347599-A1 | SYNTHESIS OF BTK INHIBITOR AND INTERMEDIATES THEREOF | Merck Sharp & Dohme LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4257186-A2 | AFFINITY MEDICANT CONJUGATES | AF Chemicals LLC (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-4251206-A1 | PROTEIN DERIVATIVES CONTAINING UNNATURAL AMINO ACIDS AND BRANCHED LINKERS | Brickbio, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-3129357-B1 | AFFINITY MEDICANT CONJUGATES | AF CHEMICALS LLC (US) | 2023-08-23 | — | — | EP | disclosed |
| EP-4210725-A1 | ANTIBODIES CONTAINING UNNATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | Brickbio, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4159795-A1 | THERAPEUTIC CONJUGATES WITH SULFATED DENDRIMERS FOR INTRACELLULAR TARGETING | ICD-Therapeutics GmbH (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-11576876-B2 | Affinity Medicant Conjugate | AF CHEMICALS, LLC (US) | 2023-02-14 | — | — | US | disclosed |
| US-4689343-A | AGRICULTURE | BAYER AKTIENGESELLSCHAFT (DE) | 1987-08-25 | — | — | US | disclosed |
| US-4684660-A | Mercaptoacyldepeptides | E. R. SQUIBB & SONS, INC. (US) | 1987-08-04 | — | — | US | disclosed |
| US-4599350-A | PHYTOPATHOGENS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-08 | — | — | US | disclosed |
| EP-0144895-A2 | Thiolan-2,4-dion-3-carboxamides | BAYER AG (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0009898-B1 | NOVEL ANTI-HYPERTENSIVE MERCAPTOACYLAMINO ACID DERIVATIVES, THEIR PREPARATION AND USE | UNIVERSITY OF MIAMI (US) | 1983-05-18 | — | — | EP | disclosed |
| EP-0078002-A2 | Herbicides containing triazolo(2,3-b)quinazolone as active ingredient, and their use as plant growth regulators | BASF Aktiengesellschaft (DE) | 1983-05-04 | — | — | EP | disclosed |
| US-4322214-A | USING A SULFUR OR SULFURIZED VAT DYE IN AN ALKALINE BATH CONTAINING A MERCAPTO COMPOUND AND A SULFITE SALT; LEVELING | ASAHI CHEMICAL COMPANY LIMITED (JP) | 1982-03-30 | — | — | US | disclosed |
| EP-0038117-A1 | Methods for preparing anti-hypertensive agents | UNIVERSITY OF MIAMI (US) | 1981-10-21 | — | — | EP | disclosed |
| EP-0009898-A1 | Novel anti-hypertensive mercaptoacylamino acid derivatives, their preparation and use | UNIVERSITY OF MIAMI (US) | 1980-04-16 | — | — | EP | disclosed |